Details of the Drug

General Information of Drug (ID: DMKVMWO)

Drug Name

RP-L201

Indication

Disease Entry	ICD 11	Status	REF
Leukocyte adhesion deficiency type 1	4A00.0Y	Phase 1/2	[1]
------------------------------------------------------------------------------------

Drug Type

Gene therapy

Cross-matching ID

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

Molecular Interaction Atlas (MIA)

Jump to Detail Molecular Interaction Atlas of This Drug

References

1	ClinicalTrials.gov (NCT03812263) A Clinical Trial to Evaluate the Safety and Efficacy of RP-L201 in Subjects With Leukocyte Adhesion Deficiency-I. U.S. National Institutes of Health.
2	Clinical pipeline report, company report or official report of Rocket Pharmaceuticals.